McKesson Corporation Company Profile (NYSE:MCK)

About McKesson Corporation (NYSE:MCK)

McKesson Corporation logoMcKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Retailers
  • Sub-Industry: Health Care Distributors
  • Symbol: NYSE:MCK
  • CUSIP: 58155Q10
  • Web:
  • Market Cap: $31.19635 billion
  • Outstanding Shares: 210,260,000
Average Prices:
  • 50 Day Moving Avg: $151.41
  • 200 Day Moving Avg: $153.02
  • 52 Week Range: $114.53 - $169.29
  • Trailing P/E Ratio: 6.73
  • Foreward P/E Ratio: 11.71
  • P/E Growth: 2.90
Sales & Book Value:
  • Annual Revenue: $199.85 billion
  • Price / Sales: 0.16
  • Book Value: $53.76 per share
  • Price / Book: 2.79
  • Annual Dividend: $1.36
  • Dividend Yield: 0.9%
  • EBIDTA: $3.94 billion
  • Net Margins: 2.42%
  • Return on Equity: 25.76%
  • Return on Assets: 4.34%
  • Debt-to-Equity Ratio: 0.64%
  • Current Ratio: 1.05%
  • Quick Ratio: 0.62%
  • Average Volume: 1.61 million shs.
  • Beta: 1.16
  • Short Ratio: 1.89

Frequently Asked Questions for McKesson Corporation (NYSE:MCK)

What is McKesson Corporation's stock symbol?

McKesson Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

How often does McKesson Corporation pay dividends? What is the dividend yield for McKesson Corporation?

McKesson Corporation declared a quarterly dividend on Wednesday, July 26th. Shareholders of record on Friday, September 1st will be paid a dividend of $0.34 per share on Monday, October 2nd. This represents a $1.36 annualized dividend and a yield of 0.91%. The ex-dividend date of this dividend is Wednesday, August 30th. This is an increase from McKesson Corporation's previous quarterly dividend of $0.28. View McKesson Corporation's Dividend History.

How were McKesson Corporation's earnings last quarter?

McKesson Corporation (NYSE:MCK) announced its quarterly earnings data on Thursday, July, 27th. The company reported $2.46 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.81 by $0.35. The firm had revenue of $51.05 billion for the quarter, compared to analysts' expectations of $51.22 billion. McKesson Corporation had a return on equity of 25.76% and a net margin of 2.42%. McKesson Corporation's quarterly revenue was up 2.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $3.50 EPS. View McKesson Corporation's Earnings History.

When will McKesson Corporation make its next earnings announcement?

McKesson Corporation is scheduled to release their next quarterly earnings announcement on Thursday, October, 26th 2017. View Earnings Estimates for McKesson Corporation.

Where is McKesson Corporation's stock going? Where will McKesson Corporation's stock price be in 2017?

15 brokers have issued twelve-month price targets for McKesson Corporation's stock. Their predictions range from $131.00 to $193.00. On average, they anticipate McKesson Corporation's share price to reach $170.00 in the next twelve months. View Analyst Ratings for McKesson Corporation.

What are analysts saying about McKesson Corporation stock?

Here are some recent quotes from research analysts about McKesson Corporation stock:

  • 1. According to Zacks Investment Research, "Over the past three months, McKesson has been trading above the broader Medical/Dental – Supplies industry. Looking forward, management expects to gain with the gradually stabilizing generic and branded markets. The company recently posted stable numbers for the fourth-quarter fiscal 2017 (ended Mar 31, 2017) wherein earnings beat the Zacks Consensus Estimate, courtesy of a strong performance in the Distribution Solutions division. To boost growth the company has acquired CoverMyMeds for approximately $1.1 billion in the recent past. Also, cost-savings efforts remain encouraging. Furthermore, an inexpensive valuation and rising estimate revision trend for the current year indicates a pocket of opportunity for the stock. On the flip side, stiff competition, currency headwind and reimbursement issues remain challenges." (7/12/2017)
  • 2. Citigroup Inc. analysts commented, "MCK yesterday announced the completion of its previously-announced agreement w/Change Healthcare (CHC) to create a new HCIT company retaining the same name, combining substantially all of CHC's business and the majority of MCK Tech. Solutions, less its EIS segment which will remain in MTS. Initial plans to merge assets were announced on 6/28/16. Mgmt provided color on the NewCo's financial implications, largely consistent with expectations, with recognition occurring on a 1-month lag (reducing guided F4Q17 adj EPS by ~$0.15). We update our estimates to fully reflect today's guidance on the NewCo, but currently assume a full FY18 RAD contribution to MCK. Net, we maintain our Buy, as headwinds appear to be stabilizing while the WMT contract should improve purchasing power, with some offsets given initial Change dilution and a likely F2H18 loss of RAD; $175 TP (+$6), ~13-14x CY17 EPS, ~17% ETR." (3/6/2017)

Who are some of McKesson Corporation's key competitors?

Who are McKesson Corporation's key executives?

McKesson Corporation's management team includes the folowing people:

  • John Harvey Hammergren, Chairman of the Board, President, Chief Executive Officer
  • James A. Beer, Chief Financial Officer, Executive Vice President
  • Kathleen D. McElligott, Executive Vice President, Chief Technology Officer, Chief Information Officer
  • Lori Ann Schechter, Executive Vice President, Chief Compliance Officer, General Counsel
  • Jorge L. Figueredo, Executive Vice President - Human Resources
  • Paul Coleman Julian, Executive Vice President, Group President
  • Bansi Nagji, Executive Vice President - Corporate Strategy and Business Development
  • Edward A. Mueller, Lead Independent Director
  • Andrew D. Bryant, Independent Director
  • N. Anthony Coles Jr. M.D., Independent Director

Who owns McKesson Corporation stock?

McKesson Corporation's stock is owned by many different of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.29%), Vanguard Group Inc. (6.70%), State Street Corp (4.56%), FMR LLC (1.47%), Northern Trust Corp (1.21%) and Bank of New York Mellon Corp (1.13%). Company insiders that own McKesson Corporation stock include Erin M Lampert, James A Beer, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Nigel A Rees, Patrick Blake, Susan R Salka and Wayne A Budd. View Institutional Ownership Trends for McKesson Corporation.

Who sold McKesson Corporation stock? Who is selling McKesson Corporation stock?

McKesson Corporation's stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, Ballentine Partners LLC, Ameriprise Financial Inc., FMR LLC, Schroder Investment Management Group, Epoch Investment Partners Inc., State Street Corp and State of New Jersey Common Pension Fund D. Company insiders that have sold McKesson Corporation stock in the last year include Erin M Lampert, John H Hammergren, M Christine Jacobs, Marie L/Ca Knowles and Wayne A Budd. View Insider Buying and Selling for McKesson Corporation.

Who bought McKesson Corporation stock? Who is buying McKesson Corporation stock?

McKesson Corporation's stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Harbour Capital Advisors LLC, Renaissance Technologies LLC, AJO LP, Kiltearn Partners LLP, Sterling Capital Management LLC, Canyon Capital Advisors LLC and Glenview Capital Management LLC. Company insiders that have bought McKesson Corporation stock in the last two years include Lori A Schechter and Susan R Salka. View Insider Buying and Selling for McKesson Corporation.

How do I buy McKesson Corporation stock?

Shares of McKesson Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is McKesson Corporation's stock price today?

One share of McKesson Corporation stock can currently be purchased for approximately $150.18.

MarketBeat Community Rating for McKesson Corporation (NYSE MCK)
Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  637 (Vote Outperform)
Underperform Votes:  299 (Vote Underperform)
Total Votes:  936
MarketBeat's community ratings are surveys of what our community members think about McKesson Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for McKesson Corporation (NYSE:MCK) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 7 Hold Ratings, 7 Buy Ratings
Consensus Rating:Hold (Score: 2.40)
Consensus Price Target: $170.00 (13.20% upside)

Analysts' Ratings History for McKesson Corporation (NYSE:MCK)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/19/2017Royal Bank Of CanadaInitiated CoverageSector Perform -> Sector Perform$168.00LowView Rating Details
9/19/2017Robert W. BairdUpgradeNeutral -> Outperform$175.00 -> $178.00LowView Rating Details
9/14/2017Morgan StanleyDowngradeOverweight -> Equal Weight$184.00 -> $172.00HighView Rating Details
9/8/2017Needham & Company LLCUpgradeHold -> Buy$179.00LowView Rating Details
8/29/2017Jefferies Group LLCSet Price TargetHold$165.00LowView Rating Details
6/29/2017Leerink SwannBoost Price TargetMarket Perform$170.00MediumView Rating Details
6/4/2017Barclays PLCSet Price TargetBuy$187.00LowView Rating Details
5/30/2017MizuhoBoost Price TargetNeutral -> Neutral$147.00 -> $168.00LowView Rating Details
5/23/2017J P Morgan Chase & CoUpgradeNeutral -> Overweight$189.00MediumView Rating Details
4/17/2017Evercore ISIReiterated RatingOutperform$166.00LowView Rating Details
3/6/2017Citigroup Inc.Boost Price TargetBuy$169.00 -> $175.00N/AView Rating Details
3/3/2017Credit Suisse GroupReiterated RatingSellN/AView Rating Details
1/18/2017Avondale PartnersUpgradeMarket Perform -> Outperform$157.00 -> $193.00N/AView Rating Details
11/11/2016Standpoint ResearchDowngradeBuy -> HoldN/AView Rating Details
10/28/2016Deutsche Bank AGDowngradeBuy -> Hold$196.00 -> $153.00N/AView Rating Details
9/19/2016ArgusReiterated RatingHoldN/AView Rating Details
9/16/2016Goldman Sachs Group, Inc. (The)DowngradeBuy -> Neutral$210.00 -> $189.00N/AView Rating Details
6/30/2016Bank of America CorporationReiterated RatingHoldN/AView Rating Details
6/29/2016FBR & CoReiterated RatingBuy$210.00N/AView Rating Details
6/1/2016Raymond James Financial, Inc.DowngradeStrong-Buy -> OutperformN/AView Rating Details
3/15/2016Cowen and CompanyDowngradeOutperform -> Market Perform$208.00 -> $173.00N/AView Rating Details
(Data available from 9/21/2015 forward)


Earnings History for McKesson Corporation (NYSE:MCK)
Earnings by Quarter for McKesson Corporation (NYSE:MCK)
Earnings History by Quarter for McKesson Corporation (NYSE MCK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2017$2.85N/AView Earnings Details
7/27/2017Q1 2018$2.81$2.46$51.22 billion$51.05 billionViewN/AView Earnings Details
5/18/2017Q4 17$3.04$3.39$49.48 billion$48.71 billionViewN/AView Earnings Details
1/25/2017Q317$2.95$3.03$50.71 billion$50.13 billionViewN/AView Earnings Details
10/27/2016Q217$3.05$2.94$24.16 billion$49.96 billionViewListenView Earnings Details
7/27/2016Q117$3.33$3.50$50.32 billion$49.73 billionViewListenView Earnings Details
5/4/2016Q416$3.14$2.44$46.83 billion$46.68 billionViewN/AView Earnings Details
1/27/2016Q316$3.13$3.18$48.97 billion$47.90 billionViewListenView Earnings Details
10/29/2015Q216$2.99$3.31$47.85 billion$48.60 billionViewListenView Earnings Details
7/29/2015Q116$2.89$3.14$46.02 billion$47.50 billionViewListenView Earnings Details
5/12/2015Q415$2.75$2.94$45.00 billion$44.93 billionViewListenView Earnings Details
2/5/2015Q315$2.61$2.89$44.81 billion$47.01 billionViewN/AView Earnings Details
10/28/2014Q215$2.73$2.79$42.99 billion$44.76 billionViewN/AView Earnings Details
7/31/2014Q115$2.34$2.49$40.65 billion$44.06 billionViewN/AView Earnings Details
5/12/2014Q414$2.40$2.55$35.89 billion$38.14 billionViewN/AView Earnings Details
1/31/2014Q314$1.85$1.45$38.57 billion$34.30 billionViewN/AView Earnings Details
10/24/2013Q214$2.03$2.27$32.16 billion$33.00 billionViewListenView Earnings Details
7/25/2013Q1 2014$1.71$2.07$32.60 billion$32.20 billionViewListenView Earnings Details
5/7/2013Q4 2013$2.30$1.45$32.01 billion$30.62 billionViewListenView Earnings Details
1/31/2013Q3 2013$1.62$1.41$30.81 billion$31.19 billionViewListenView Earnings Details
10/25/2012$1.78$1.92ViewN/AView Earnings Details
7/26/2012$1.48$1.55ViewN/AView Earnings Details
4/30/2012$2.04$2.09ViewN/AView Earnings Details
1/30/2012$1.38$1.40ViewN/AView Earnings Details
10/25/2011$1.38$1.63ViewN/AView Earnings Details
7/28/2011$1.10$1.27ViewN/AView Earnings Details
5/3/2011$1.60$1.66ViewN/AView Earnings Details
1/31/2011$1.12$1.12ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for McKesson Corporation (NYSE:MCK)
2017 EPS Consensus Estimate: $12.80
2018 EPS Consensus Estimate: $11.96
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$3.36$3.40$3.38
Q2 20172$3.10$3.10$3.10
Q3 20172$2.85$3.46$3.16
Q4 20173$2.99$3.51$3.17
Q1 20182$2.85$2.88$2.87
Q2 20182$2.80$2.82$2.81
Q3 20182$2.80$2.90$2.85
Q4 20182$3.08$3.78$3.43
(Data provided by Zacks Investment Research)


Current Dividend Information for McKesson Corporation (NYSE:MCK)
Next Dividend:10/2/2017
Annual Dividend:$1.36
Dividend Yield:0.91%
Dividend Growth:10.10% (3 Year Average)
Payout Ratio:6.07% (Trailing 12 Months of Earnings)
11.24% (Based on This Year's Estimates)
10.60% (Based on Next Year's Estimates)
Track Record:4 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for McKesson Corporation (NYSE:MCK)

Dividend History by Quarter for McKesson Corporation (NYSE MCK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for McKesson Corporation (NYSE:MCK)
Insider Ownership Percentage: 1.20%
Institutional Ownership Percentage: 85.16%
Insider Trades by Quarter for McKesson Corporation (NYSE:MCK)
Institutional Ownership by Quarter for McKesson Corporation (NYSE:MCK)
Insider Trades by Quarter for McKesson Corporation (NYSE:MCK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/7/2017Erin M. LampertSVPSell900$155.65$140,085.00View SEC Filing  
8/21/2017M Christine JacobsDirectorSell1,083$145.43$157,500.69View SEC Filing  
7/31/2017Marie L/Ca KnowlesDirectorSell1,083$162.55$176,041.65View SEC Filing  
6/1/2017John H HammergrenChairmanSell38,619$163.76$6,324,247.44View SEC Filing  
5/31/2017Erin M LampertSVPSell809$160.66$129,973.94View SEC Filing  
5/30/2017Erin M LampertSVPSell404$160.53$64,854.12View SEC Filing  
5/30/2017John H HammergrenChairmanSell19,316$162.31$3,135,179.96View SEC Filing  
3/29/2017John H HammergrenChairmanSell100,500$150.44$15,119,220.00View SEC Filing  
3/2/2017John H HammergrenChairmanSell100,500$150.49$15,124,245.00View SEC Filing  
12/5/2016Wayne A. BuddDirectorSell723$145.77$105,391.71View SEC Filing  
11/30/2016Lori A SchechterEVPBuy692$144.52$100,007.84View SEC Filing  
11/2/2016Susan R SalkaDirectorBuy1,000$136.35$136,350.00View SEC Filing  
10/31/2016Erin M LampertSVPSell921$123.99$114,194.79View SEC Filing  
10/3/2016Erin M. LampertSVPSell1,739$165.94$288,569.66View SEC Filing  
9/12/2016John H HammergrenChairmanSell100,500$180.77$18,167,385.00View SEC Filing  
9/12/2016Wayne A BuddDirectorSell2,309$179.70$414,927.30View SEC Filing  
9/6/2016John H HammergrenChairmanSell100,500$184.22$18,514,110.00View SEC Filing  
8/22/2016M Christine JacobsDirectorSell915$193.78$177,308.70View SEC Filing  
8/1/2016Marie L/Ca KnowlesDirectorSell915$192.73$176,347.95View SEC Filing  
7/14/2016James A BeerCFOSell5,500$199.00$1,094,500.00View SEC Filing  
5/25/2016John H HammergrenCEOSell37,420$182.87$6,842,995.40View SEC Filing  
5/25/2016Patrick BlakeEVPSell6,322$182.87$1,156,104.14View SEC Filing  
5/24/2016John H HammergrenCEOSell18,709$182.06$3,406,160.54View SEC Filing  
5/24/2016Lori A SchechterEVPSell107$182.06$19,480.42View SEC Filing  
5/23/2016John H HammergrenCEOSell18,718$179.33$3,356,698.94View SEC Filing  
5/23/2016Patrick BlakeEVPSell3,162$179.33$567,041.46View SEC Filing  
5/10/2016John H HammergrenCEOSell101,833$170.71$17,383,911.43View SEC Filing  
4/25/2016John H HammergrenCEOSell101,833$176.81$18,005,092.73View SEC Filing  
4/4/2016John H HammergrenCEOSell45,300$159.00$7,202,700.00View SEC Filing  
3/15/2016Nigel A ReesSVPSell6,000$157.59$945,540.00View SEC Filing  
2/2/2016Susan R SalkaDirectorBuy1,000$156.21$156,210.00View SEC Filing  
2/1/2016Lori A. SchechterEVPSell2,476$159.73$395,491.48View SEC Filing  
1/4/2016John H. HammergrenCEOSell101,833$194.11$19,766,803.63View SEC Filing  
12/1/2015John H. HammergrenCEOSell101,833$190.06$19,354,379.98View SEC Filing  
11/24/2015John H. HammergrenCEOSell56,533$190.01$10,741,835.33View SEC Filing  
10/12/2015John H. HammergrenCEOSell101,835$190.51$19,400,585.85View SEC Filing  
8/13/2015Paul C JulianEVPSell55,666$214.54$11,942,583.64View SEC Filing  
7/15/2015Paul C JulianEVPSell27,833$234.04$6,514,035.32View SEC Filing  
7/14/2015Paul C JulianEVPSell27,833$232.86$6,481,192.38View SEC Filing  
6/17/2015Paul C JulianEVPSell55,668$234.06$13,029,652.08View SEC Filing  
5/28/2015John H HammergrenCEOSell60,000$238.53$14,311,800.00View SEC Filing  
5/28/2015Lori A SchechterEVPSell1,468$238.22$349,706.96View SEC Filing  
5/26/2015John H HammergrenCEOSell30,062$238.97$7,183,916.14View SEC Filing  
5/26/2015Paul C JulianEVPSell15,289$238.97$3,653,612.33View SEC Filing  
5/22/2015Jorge FigueredoEVPSell20,775$240.11$4,988,285.25View SEC Filing  
5/15/2015Jorge FigueredoEVPSell8,525$240.00$2,046,000.00View SEC Filing  
2/17/2015Randall N SprattEVPSell44,523$225.00$10,017,675.00View SEC Filing  
2/12/2015Randall N SprattEVPSell7,477$225.00$1,682,325.00View SEC Filing  
2/10/2015Alton F Irby IIIDirectorSell5,000$220.76$1,103,800.00View SEC Filing  
2/10/2015Nigel A ReesMajor ShareholderSell9,000$220.42$1,983,780.00View SEC Filing  
1/28/2015John H HammergrenCEOSell64,521$219.52$14,163,649.92View SEC Filing  
1/26/2015Brian Scott TylerEVPSell5,431$216.62$1,176,463.22View SEC Filing  
1/26/2015John H HammergrenCEOSell35,479$219.07$7,772,384.53View SEC Filing  
1/7/2015John H HammergrenCEOSell77,100$214.00$16,499,400.00View SEC Filing  
12/8/2014John H HammergrenCEOSell12,200$214.01$2,610,922.00View SEC Filing  
11/28/2014Patrick BlakeEVPSell19,000$210.00$3,990,000.00View SEC Filing  
11/24/2014John H HammergrenCEOSell100,000$209.25$20,925,000.00View SEC Filing  
11/12/2014Paul C JulianEVPSell74,666$202.51$15,120,611.66View SEC Filing  
10/31/2014Patrick BlakeEVPSell38,000$204.68$7,777,840.00View SEC Filing  
10/8/2014Paul C JulianEVPSell74,667$195.86$14,624,278.62View SEC Filing  
10/7/2014John H HammergrenCEOSell100,000$197.28$19,728,000.00View SEC Filing  
9/10/2014Paul C JulianEVPSell74,667$196.76$14,691,478.92View SEC Filing  
8/29/2014Jorge FigueredoEVPSell24,500$195.00$4,777,500.00View SEC Filing  
8/8/2014M Christine JacobsDirectorSell2,619$189.88$497,295.72View SEC Filing  
8/5/2014Marie L/Ca KnowlesDirectorSell785$192.10$150,798.50View SEC Filing  
6/2/2014Patrick BlakeEVPSell15,000$190.00$2,850,000.00View SEC Filing  
5/29/2014Paul C JulianEVPSell21,057$186.89$3,935,342.73View SEC Filing  
5/28/2014Alton F Irby IIIDirectorSell4,000$182.73$730,920.00View SEC Filing  
5/28/2014John H HammergrenCEOSell125,596$183.31$23,023,002.76View SEC Filing  
5/28/2014Jorge FigueredoEVPSell20,542$183.30$3,765,348.60View SEC Filing  
5/27/2014Brian Scott TylerEVPSell3,916$183.30$717,802.80View SEC Filing  
5/22/2014Brian Scott TylerEVPSell8,250$184.17$1,519,402.50View SEC Filing  
3/21/2014Jorge FigueredoEVPSell23,684$185.81$4,400,724.04View SEC Filing  
3/10/2014Patrick BlakeEVPSell38,750$180.36$6,988,950.00View SEC Filing  
2/4/2014Brian Scott TylerEVPSell6,250$169.68$1,060,500.00View SEC Filing  
1/22/2014Alton Irby IIIDirectorSell1,300$167.98$218,374.00View SEC Filing  
11/1/2013Nigel A ReesCFOSell7,000$158.72$1,111,040.00View SEC Filing  
10/29/2013Brian Scott TylerEVPSell8,250$153.44$1,265,880.00View SEC Filing  
10/11/2013Brian Scott TylerEVPSell9,000$138.51$1,246,590.00View SEC Filing  
10/9/2013Paul JulianEVPSell84,000$134.04$11,259,360.00View SEC Filing  
10/8/2013Brian Scott TylerEVPSell9,000$138.00$1,242,000.00View SEC Filing  
9/11/2013Paul C JulianEVPSell84,000$126.20$10,600,800.00View SEC Filing  
8/7/2013Paul JulianEVPSell84,000$123.29$10,356,360.00View SEC Filing  
8/6/2013Marie L/Ca KnowlesDirectorSell1,223$123.54$151,089.42View SEC Filing  
7/30/2013Brian Scott TylerEVPSell6,250$123.94$774,625.00View SEC Filing  
6/19/2013Paul C JulianEVPSell84,750$114.89$9,736,927.50View SEC Filing  
6/14/2013David M LawrenceDirectorSell7,500$114.28$857,100.00View SEC Filing  
6/14/2013Jorge FigueredoEVPSell6,250$115.00$718,750.00View SEC Filing  
6/10/2013Jorge FigueredoEVPSell10,000$115.00$1,150,000.00View SEC Filing  
6/4/2013Jorge FigueredoEVPSell22,500$113.63$2,556,675.00View SEC Filing  
5/30/2013Laureen SeegerEVPSell57,750$114.89$6,634,897.50View SEC Filing  
5/29/2013John H HammergrenCEOSell230,484$115.21$26,554,061.64View SEC Filing  
5/29/2013Randall N SprattEVPSell32,226$115.21$3,712,757.46View SEC Filing  
5/28/2013Brian Scott TylerEVPSell6,023$116.33$700,655.59View SEC Filing  
5/28/2013Jeffrey C CampbellCFOSell73,102$116.33$8,503,955.66View SEC Filing  
5/24/2013Laureen SeegerEVPSell17,250$116.50$2,009,625.00View SEC Filing  
5/22/2013Laureen SeegerEVPSell17,250$118.13$2,037,742.50View SEC Filing  
5/20/2013Brian Scott TylerEVPSell5,000$117.81$589,050.00View SEC Filing  
5/15/2013Nigel A ReesVPSell8,000$116.00$928,000.00View SEC Filing  
5/10/2013Brian Scott TylerEVPSell6,250$115.59$722,437.50View SEC Filing  
5/10/2013John H HammergrenCEOSell75,000$115.30$8,647,500.00View SEC Filing  
1/18/2013Jorge FigueredoEVPSell2,500$103.22$258,050.00View SEC Filing  
1/17/2013Laureen SeegerEVPSell17,250$103.00$1,776,750.00View SEC Filing  
9/4/2012Paul C JulianEVPSell36,250$87.02$3,154,475.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for McKesson Corporation (NYSE:MCK)
Latest Headlines for McKesson Corporation (NYSE:MCK)
DateHeadline logoAnalyst 'Takes A Flyer' On McKesson, Upgrades Ahead Of Earnings - September 20 at 6:09 AM logoRobert W. Baird Upgrades McKesson Corporation (MCK) to "Outperform" - September 20 at 12:08 AM logoRoyal Bank Of Canada Initiates Coverage on McKesson Corporation (MCK) - September 19 at 7:38 AM logoMcKesson Corporation (MCK) Receives Average Rating of "Hold" from Analysts - September 17 at 5:06 PM logoMcKesson Corporation (MCK) Downgraded by Morgan Stanley - September 16 at 9:04 PM logoMcKesson Increases Hurricane Relief Commitment to $600,000 ... - Business Wire (press release) - September 15 at 6:20 AM logoStocks slip as tech and healthcare stumble - September 14 at 11:34 AM logoMarkets Right Now: Tech and health care stocks stumble - September 14 at 10:06 AM logoMcKesson Corp. – Value Analysis (NYSE:MCK) : September 14, 2017 - September 14 at 7:32 AM logoMcKesson Corp. breached its 50 day moving average in a Bullish Manner : MCK-US : September 12, 2017 - September 13 at 6:22 AM logoHead-To-Head Contrast: McKesson Corporation (MCK) and MWI Veterinary Supply (MWIV) - September 12 at 12:30 PM logoMcKesson Corporation Expected to Earn Q4 2018 Earnings of $3.78 Per Share (MCK) - September 11 at 9:42 AM logoVitaliy Katsenelson's Contrarian Edge: This drug industry leader could be healthy for your stock portfolio - September 11 at 5:57 AM logoThis drug industry leader could be healthy for your stock portfolio - September 11 at 5:40 AM logoHurricane Irma: McKesson Prepares to Support Healthcare Providers, Pharmacies and First Responders - September 9 at 6:05 AM logoMcKesson Ventures Leads $25 Million Financing Round For Truveris - September 9 at 6:05 AM logoMcKesson Corporation (MCK) Expected to Post Quarterly Sales of $51.60 Billion - September 9 at 3:44 AM logoMcKesson Corporation (MCK) Upgraded to "Buy" at Needham & Company LLC - September 8 at 9:18 PM logoInsider Selling: McKesson Corporation (MCK) SVP Sells 900 Shares of Stock - September 8 at 8:20 PM logoContrasting MWI Veterinary Supply (MWIV) & McKesson Corporation (MCK) - September 4 at 12:34 PM logoReviewing McKesson Corporation (MCK) & MWI Veterinary Supply (MWIV) - September 1 at 9:03 AM logoMcKesson Commits More than $300,000 in Relief Support for ... - Business Wire (press release) - September 1 at 3:48 AM logoHow World's Largest Drug Distributor Is Helping Harvey Victims Treat Snakebites - September 1 at 3:48 AM logoOversold Conditions For McKesson (MCK) - August 30 at 6:27 AM logoMcKesson Corporation (MCK) Given a $165.00 Price Target by Jefferies Group LLC Analysts - August 29 at 9:28 PM logoDigital Health Market in Asia-Pacific to Witness Fastest Growth by 2022, Globally: P&S Market Research - August 28 at 5:30 AM logoMcKesson Heavily Oversold At $147 - Seeking Alpha - August 25 at 8:19 AM logoPharmacy Automation Devices Market: Global Trends, Size, Share, Growth Drivers, Opportunities and 2021 Forecasts Discussed in New Research Report - August 24 at 9:04 AM logoMcKesson Corporation (MCK) Given Average Rating of "Hold" by Analysts - August 23 at 6:46 PM logoMcKesson Corporation to Present at the Morgan Stanley Global Healthcare Conference - Business Wire (press release) - August 22 at 8:51 PM logoMcKesson Corporation to Present at the Morgan Stanley Global Healthcare Conference - August 22 at 8:51 PM logoMcKesson Corporation (MCK) Director M Christine Jacobs Sells 1,083 Shares - August 22 at 7:34 PM logo Analysts Expect McKesson Corporation (MCK) Will Post Quarterly Sales of $51.60 Billion - August 22 at 1:56 PM logoEarnings Review and Free Research Report: Cardinal Health Adjusted Diluted EPS increased 15% - August 21 at 8:16 AM logoMcKesson Corporation (MCK) Downgraded to "Strong Sell" at BidaskClub - August 19 at 4:38 PM logoMcKesson Banks on Distribution Business Amid Pricing Woes - Nasdaq - August 18 at 6:36 AM logoHead to Head Contrast: MWI Veterinary Supply (MWIV) vs. McKesson Corporation (MCK) - August 17 at 10:30 AM logoAllscripts Stock Climbs, Cantor Upgrades After McKesson Deal - August 16 at 6:02 AM logoMcKesson (MCK) Shares Cross Below 200 DMA - August 15 at 1:22 AM logoDrug Distributor Has Some Upside - August 15 at 1:22 AM logoETFs with exposure to McKesson Corp. : August 14, 2017 - August 15 at 1:22 AM logoSee what the IHS Markit Score report has to say about McKesson Corp. - August 12 at 7:43 PM logoMcKesson: Why I'm Long - August 11 at 6:22 AM logoAllscripts to acquire McKesson's Enterprise Information Solutions business - GlobeNewswire (press release) - August 5 at 7:26 PM logoBRIEF-James Beer, EVP, CFO of Mckesson Corporation, joins Alaska Air board of directors - August 5 at 2:33 AM logoJames Beer, EVP, CFO of McKesson Corporation, joins Alaska Air Group Board of Directors - PR Newswire (press release) - August 4 at 1:27 AM logoAllscripts buys McKesson's hospital and health system IT unit for $185M - August 3 at 6:28 PM logoBaron & Budd, Greene Ketchum, Levin Papantonio File Suit Against Pharmaceutical Distributors for Role in Creating Opioid Crisis in Four Ohio Counties - August 3 at 4:40 AM logoMcKesson: Margin Of Safety - Seeking Alpha - August 2 at 4:06 AM logoHow Safe Is McCormick's Dividend? - August 2 at 4:06 AM



McKesson Corporation (MCK) Chart for Thursday, September, 21, 2017

This page was last updated on 9/21/2017 by Staff